Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.1 USD | -5.58% | -6.20% | +9.86% |
Chart calendar SpringWorks Therapeutics, Inc.
Upcoming events on SpringWorks Therapeutics, Inc.
Past events on SpringWorks Therapeutics, Inc.
2024-03-12 09:00 am | Barclays Global Healthcare Conference |
2024-03-04 02:50 pm | TD Cowen Health Care Conference |
2024-02-27 06:30 am | Q4 2023 Earnings Release |
2024-02-08 02:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
2024-01-08 10:30 am | JPMorgan Healthcare Conference |
2023-11-30 08:45 am | Evercore ISI HealthCONx Conference |
2023-11-28 08:00 am | OGSIVEO Approval Call |
2023-11-16 08:30 am | ReNeu Phase IIb Trial Topline Results Call |
2023-11-02 12:30 pm | Connective Tissue Oncology Society Meeting - Poster No: P 188 |
2023-11-02 06:30 am | Q3 2023 Earnings Release |
2023-08-02 06:30 am | Q2 2023 Earnings Release |
2023-06-12 02:20 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
2023-06-03 05:30 pm | American Society of Clinical Oncology Conference - Abstract No: 11514 |
2023-06-03 02:15 pm | American Society of Clinical Oncology Meeting - Abstract No: 11564 |
2023-05-31 01:00 pm | TD Cowen Oncology Innovation Summit |
2023-05-24 01:00 pm | Annual General Meeting |
2023-05-09 02:20 pm | Bank of America Healthcare Conference |
2023-05-03 06:30 am | Q1 2023 Earnings Release |
2023-04-17 03:50 pm | American Association for Cancer Research Meeting - Abstract Number #: CT033 |
2023-04-17 03:20 pm | American Association for Cancer Research Meeting - Abstract No: CT031 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 35,0 21,0 66.67% | 0,00 0,00 - | 0,00 0,00 - | 5,45 1,01 439.77% | 86,9 |
EBITDA Million USD | Released Forecast Spread | -59,0 -60,0 1.64% | -46,0 -78,6 41.54% | -173 -151 -14.43% | -280 -275 -1.8% | -341 -334 -2.28% | -342 |
EBIT Million USD | Released Forecast Spread | -59,2 -59,2 -0.12% | -46,3 -59,4 22.01% | -173 -156 -11.27% | -281 -275 -1.95% | -343 -332 -3.41% | -337 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -58,3 -58,1 -0.28% | -45,6 -44,7 -2.01% | -174 -155 -12.54% | -277 -275 -1.02% | -325 -314 -3.56% | -312 |
Net income Million USD | Released Forecast Spread | -50,6 -58,2 13.06% | -45,6 -44,9 -1.58% | -174 -154 -13.22% | -277 -276 -0.54% | -325 -314 -3.41% | -330 |
EPS USD | Released Forecast Spread | -3,81 -2,33 -63.73% | -1,05 -1,36 23% | -3,59 -3,24 -10.8% | -5,21 -5,25 0.67% | -5,15 -4,92 -4.69% | -4,69 |
Announcement Date | 12/03/20 | 25/02/21 | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 5,45 0,90 502.99% | 11,9 | 19,1 | 27,1 | 39,8 | 45,7 |
EBITDA Million USD | Released Forecast Spread | -55,7 -42,0 -32.5% | -61,4 -57,0 -7.65% | -68,8 -64,0 -7.53% | -71,5 -73,0 2.02% | -78,2 -76,0 -2.89% | -77,4 -84,0 7.8% | -82,5 -79,0 -4.39% | |||||||
EBIT Million USD | Released Forecast Spread | -55,8 -41,9 -33.18% | -61,5 -57,7 -6.58% | -69,0 -63,8 -8.24% | -71,7 -70,5 -1.71% | -78,5 -73,0 -7.45% | -77,7 -78,9 1.53% | -82,9 -80,0 -3.63% | -84,0 -86,1 2.49% | -98,5 -88,2 -11.68% | -89,8 | -85,8 | -78,5 | -73,4 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,1 -41,4 -35.51% | -61,8 -57,0 -8.45% | -69,1 -63,3 -9.03% | -72,4 -70,6 -2.6% | -74,2 -72,9 -1.72% | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -85,6 | -84,2 | -77,7 | -70,0 | |
Net income Million USD | Released Forecast Spread | -56,1 -41,4 -35.51% | -61,8 -57,0 -8.45% | -69,1 -63,3 -9.03% | -72,4 -70,6 -2.6% | -74,2 -72,9 -1.82% | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -85,6 | -84,2 | -77,7 | -70,0 | |
EPS USD | Released Forecast Spread | -1,16 -0,88 -32.12% | -1,26 -1,05 -19.93% | -1,41 -1,26 -12.26% | -1,37 -1,32 -3.99% | -1,17 -1,22 4.24% | -1,18 -1,25 5.83% | -1,25 -1,26 0.89% | -1,27 -1,33 4.54% | -1,45 -1,24 -17.2% | -1,19 | -1,17 | -1,10 | -1,05 | -1,16 |
Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 03/05/23 | 02/08/23 | 02/11/23 | 27/02/24 | - | - | - | - | - |
Past sector events for SpringWorks Therapeutics, Inc.
2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SWTX Stock
- Calendar SpringWorks Therapeutics, Inc.